TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update
NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held on Monday, May 1, 2023, at 8:30 ET to discuss results for the first quarter 2023 and provide a business outlook for remainder of the year. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call.
Related news for (TGTX)
- Innovation Ignites, Buybacks Surge, and Macy’s Delivers a Retail Revival
- TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
- TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
- TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
